EAACI Congress 2024

31 May - 03 June 2024 Valencia, Spain

TPS12 - Allergen immunotherapy 1

Friday 31 May, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
Allergenic profile of sensitization in an allergic Spanish population
Allergenic properties of various peanut extracts prepared using commercial peanut flours
Biological standardization in vivo of a reference extract of Phleum pratense
Build-Up of Wasp Venom Immunotherapy with Alutard-Depot SQ during Supply Shortage: A Retrospective Case Series
Control of symptoms of allergic rhinitis after three years of sublingual immunotherapy with an antiallergic biologically standardized vaccine in the form of sublingual tablets-lyophilizates of ragweed pollen extract
Diverse IgE reactivity profiles in patients undergoing allergen immunotherapy, the reflection of regional sensitization - pilot study
Microneedles-based transdermal allergen specific immunotherapy protects against gliadin induced anaphylaxis in a mouse model
Molecular tools in support to walnut oral immunotherapy
Mugwort – Phyto or Immunotherapy?
Murine IgG1 corresponding to human IgG4 increased by subcutaneous immunotherapy suppressed activation of group 2 innate lymphoid cells
Non-Allergist Physician Algorithm for Prescribing Allergen Immunotherapy
Outcomes of Bee Re-sting After Cessation of Venom Immunotherapy
The clinical value of allergen detection panel in Guangzhou, southern China: A big data study based on allergen detection in the past 7 years
Use of the AllergyVax Doctor app to evaluate the correlation between adherence to treatment and control of rhinitis and asthma in patients during treatment with SLIT